Quinlan Paul T sold ORKA
October 20, 2026 · Form 4 insider transaction
Quinlan Paul T sold 3,000 shares of Oruka Therapeutics, Inc. at $79.49 per share, a transaction worth $238.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$79.49
Total value
$238.5K
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 20, 2026
Filing dateOctober 20, 2026
Shares owned after29,995
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.21 to $79.72, inclusive.